hydroquinone and tanespimycin

hydroquinone has been researched along with tanespimycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, J; Biggs, K; Curtis, M; Douglas, M; Fritz, CC; Ge, J; Lim, AR; Normant, E; Palombella, VJ; Pink, MM; Porter, JR; Tibbits, TT; West, K; Wylie, AA	1

Other Studies

1 other study(ies) available for hydroquinone and tanespimycin

Article	Year
The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. Molecular cancer therapeutics, 2009, Volume: 8, Issue:12 Topics: Animals; Benzoquinones; Cell Line, Tumor; Cell Proliferation; HCT116 Cells; HSP90 Heat-Shock Proteins; HT29 Cells; Humans; Hydroquinones; Immunoblotting; K562 Cells; Lactams, Macrocyclic; Male; Mice; Mice, Nude; Mutation; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Protein Binding; Tumor Burden; Xenograft Model Antitumor Assays	2009

Article

Year

The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo.

Molecular cancer therapeutics, 2009, Volume: 8, Issue:12

Topics: Animals; Benzoquinones; Cell Line, Tumor; Cell Proliferation; HCT116 Cells; HSP90 Heat-Shock Proteins; HT29 Cells; Humans; Hydroquinones; Immunoblotting; K562 Cells; Lactams, Macrocyclic; Male; Mice; Mice, Nude; Mutation; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Protein Binding; Tumor Burden; Xenograft Model Antitumor Assays

2009